N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide
|
Basic information |
| Metabolite name | N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide |
 | HMDB0247190 |
 |
N/A |
 |
44602431 |
| Synonyms | Butyryl-l-homosErine lactone; |
| No. of studies | 1 |
|
Basic information |
| Metabolite name | N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide |
| HMDB0247190 |
|
N/A |
|
44602431 |
| Synonyms | Butyryl-l-homosErine lactone; |
| No. of studies | 1 |
|
Relationship between N-[(3s)-2-Oxotetrahydrofuran-3-Yl]butanamide and depression (count: 1) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M830 | Type1 | corticosterone group vs. control group | Brain | Swiss mouse | Down |
| Study M830 | Type2 | corticosterone + acupoint catgut embedding group vs. corticosterone group | Brain | Swiss mouse | Up |